Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020. https://doi.org/10.1182/blood.2019000989.

Article  PubMed  PubMed Central  Google Scholar 

Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis. Blood. 2023. https://doi.org/10.1182/blood.2023022222.

Article  PubMed  PubMed Central  Google Scholar 

Tsai FD, Lindsley RC. Clonal hematopoiesis in the inherited bone marrow failure syndromes. Blood. 2020. https://doi.org/10.1182/blood.2019000990.

Article  PubMed  PubMed Central  Google Scholar 

Gutierrez-Rodrigues F, Sahoo S, Wlodarski MW, Young NS. Somatic mosaicism in inherited bone marrow failure syndromes. Best Pract Res Clin Haematol. 2021. https://doi.org/10.1016/j.beha.2021.101279.

Article  PubMed  PubMed Central  Google Scholar 

Attardi E, Corey SJ, Wlodarski MW. Clonal hematopoiesis in children with predisposing conditions. Semin Hematol. 2024. https://doi.org/10.1053/j.seminhematol.2024.01.005.

Article  PubMed  Google Scholar 

Schratz KE. Clonal evolution in inherited marrow failure syndromes predicts disease progression. Hematology: Am Soc Hematol Educ Program. 2023;2023(1). https://doi.org/10.1182/hematology.2023000469.

Gutierrez-Rodrigues F, Groarke EM, Thongon N, et al. Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations. Blood. 2024. https://doi.org/10.1182/blood.2024025023.

Article  PubMed  PubMed Central  Google Scholar 

Revy P, Kannengiesser C, Fischer A, Revy P, Kannengiesser C, Fischer A. Somatic genetic rescue in Mendelian haematopoietic diseases. Nature Reviews Genetics 2019 20:10. 2019. https://doi.org/10.1038/s41576-019-0139-x.

Article  Google Scholar 

Savage SANM. Dyskeratosis congenita and related telomere biology disorders. GeneReviews® [Internet]. 2009 [Updated 2023 Jan 19];.

Revy P, Kannengiesser C, Bertuch AA, Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nat Rev Genet. 2022. https://doi.org/10.1038/s41576-022-00527-z.

Article  PubMed  Google Scholar 

Mir SM, Tehrani SS, Goodarzi G, et al. Shelterin complex at telomeres: implications in ageing. Clin Interv Aging. 2020. https://doi.org/10.2147/CIA.S256425.

Article  PubMed  PubMed Central  Google Scholar 

Jones-Weinert C, Mainz L, Karlseder J. Telomere function and regulation from mouse models to human ageing and disease. Nat Rev Mol Cell Biol. 2024. https://doi.org/10.1038/s41580-024-00800-5.

Article  PubMed  PubMed Central  Google Scholar 

Hamma T, Ferré-D’Amaré AR, The box HACA, ribonucleoprotein, complex. Interplay of RNA and protein structures in post-transcriptional RNA modification. J Biol Chem. 2009;285(2). https://doi.org/10.1074/jbc.R109.076893.

Savage SA, Bertuch AA. Different phenotypes with different endings—telomere biology disorders and cancer predisposition with long telomeres. Br J Haematol. 2024. https://doi.org/10.1111/bjh.19851.

Article  PubMed  PubMed Central  Google Scholar 

Claude E, Decottignies A. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof. Curr Opin Genet Dev. 2020. https://doi.org/10.1016/j.gde.2020.01.002.

Article  PubMed  Google Scholar 

Chiba K, Lorbeer FK, Shain AH, et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science. 2017. https://doi.org/10.1126/science.aao0535.

Article  PubMed  PubMed Central  Google Scholar 

Dratwa M, Wysoczańska B, Łacina P, Kubik T, Bogunia-Kubik K. TERT—regulation and roles in cancer formation. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.589929.

Article  PubMed  PubMed Central  Google Scholar 

Siteni S, Grichuk A, Shay JW. Telomerase in cancer therapeutics. Cold Spring Harb Perspect Biol. 2024. https://doi.org/10.1101/cshperspect.a041703.

Article  PubMed  PubMed Central  Google Scholar 

SA S. Telomeres and Human Disease - PubMed. Cold Spring Harb Perspect Biol. 2025. https://doi.org/10.1101/cshperspect.a041684.

Stevens KB, Raj HA, Carson H, Savage SA, Agarwal S. Publication of second edition telomere biology disorders: diagnosis and management guidelines. Blood. 2022. https://doi.org/10.1182/blood-2022-171040.

Article  PubMed  PubMed Central  Google Scholar 

Catto LFB, Aggarwal N, Shalhoub R et al. Clinical and molecular features of immunodeficiency in patients with telomere biology disorders. Blood. https://doi.org/10.1182/blood.2024026735

Rolles B, Caballero-Oteyza A, Proietti M, et al. Telomere biology disorders may manifest as common variable immunodeficiency (CVID). Clin Immunol. 2023. https://doi.org/10.1016/j.clim.2023.109837.

Article  PubMed  Google Scholar 

W CL, H VS, T CC, et al. Short telomere syndromes cause a primary T cell immunodeficiency - PubMed. J Clin Investig. 2018;128(12). https://doi.org/10.1172/JCI120216.

AJ HT. The evolving genetic landscape of telomere biology disorder dyskeratosis congenita - PubMed. EMBO Mol Med. 2024;16(10). https://doi.org/10.1038/s44321-024-00118-x.

Tometten M, Beier F, Kirschner M, et al. Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort. Blood Adv. 2025;13;9.

Sanz-Moreno A, Becker L, Xie K, et al. Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita. Sci Adv. 2025. https://doi.org/10.1126/sciadv.adp8093.

Article  PubMed  PubMed Central  Google Scholar 

Kvarnung M, Pettersson M, Chun-on P, et al. Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder. Eur J Hum Genet. 2024. https://doi.org/10.1038/s41431-024-01722-8.

Article  PubMed  PubMed Central  Google Scholar 

Kochman R, Ba I, Yates M, et al. Heterozygous RPA2 variant as a novel genetic cause of telomere biology disorders. Genes Dev. 2024;38(15–16). https://doi.org/10.1101/gad.352032.124.

Niewisch MR, Giri N, McReynolds LJ, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022. https://doi.org/10.1182/blood.2021013523.

Article  PubMed  PubMed Central  Google Scholar 

Tummala H, Collopy LC, Walne AJ. Homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita–like phenotypes. Blood. 2018. https://doi.org/10.1182/blood-2018-03-837799.

Article  PubMed  PubMed Central  Google Scholar 

Guo Y, Kartawinata M, Li J. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood. 2014. https://doi.org/10.1182/blood-2014-08-596445.

Article  PubMed  PubMed Central  Google Scholar 

Kocak H, Ballew BJ, Bisht K. Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev. 2014. https://doi.org/10.1101/gad.248567.114.

Article  PubMed  PubMed Central  Google Scholar 

Hoffman TW, Vis J, Smagt J. Pulmonary fibrosis linked to variants in the ACD gene, encoding the telomere protein TPP1. Eur Respir J. 2019. https://doi.org/10.1183/13993003.00809-2019.

Article  PubMed  PubMed Central  Google Scholar 

Keller RB, Gagne KE, Usmani GN. CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer. 2012. https://doi.org/10.1002/pbc.24193.

Article  PubMed  PubMed Central  Google Scholar 

Walne AJ, Bhagat T, Kirwan M. Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica. 2013. https://doi.org/10.3324/haematol.2012.071068.

Article  PubMed  Google Scholar 

Lin H, Gong L, Zhan S, Wang Y, Liu A. Novel biallelic missense mutations in CTC1 gene identified in a Chinese family with Coats plus syndrome. J Neurol Sci. 2017. https://doi.org/10.1016/j.jns.2017.09.041.

Article  PubMed  PubMed Central  Google Scholar 

Sargolzaeiaval F, Zhang J, Schleit J. CTC 1 mutations in a Brazilian family with progeroid features and recurrent bone fractures. Mol Genet Genomic Med. 2018. https://doi.org/10.1002/mgg3.495.

Article  PubMed